临床肿瘤学杂志

• 综述与讲座 • 上一篇    下一篇

口服氟尿嘧啶类制剂治疗进展期结直肠癌的现状与进展

赵文英,陈景华
  

  1. 241001 安徽芜湖 皖南医学院弋矶山医院肿瘤内科
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2013-11-30 发布日期:2013-11-30

Recent status and progression of oral fluorouracil in treatment of advanced colorectal cancer

ZHAO Wenying,CHEN Jinghua.   

  1. Department of Medical Oncology, Yijishan Hospital of Wannan Medical College, Wuhu 241001, China
  • Received:1900-01-01 Revised:1900-01-01 Online:2013-11-30 Published:2013-11-30

摘要: 氟尿嘧啶类化疗药物在结直肠癌治疗中占有非常重要的地位,口服氟尿嘧啶类制剂包括优福啶、脱氧氟尿苷、卡培他滨、替吉奥等,与传统氟尿嘧啶(5-FU)相比具有高效、低毒、应用方便等优点,其临床应用也越来越广泛。本文回顾分析了5FU的作用机制以及口服氟尿嘧啶类制剂的研发情况,并就口服氟尿嘧啶类制剂治疗进展期结直肠癌的现状与进展作一综述。

Abstract: Fluorouracil is important in the treatment of colorectal cancer. Compared with traditional 5fluorouracil, the oral fluorouracil(including UFT, doxifluridine, capecitabine, S1, etc) has numerous advantages such as: high efficiency, low toxicity, ease of application and so on. It is widely used in clinical. This review analyzes the mechanism of 5FU and the development of oral fluorouracil, and the recent status and progression of oral fluorouracil in treatment of advanced colorectal cancer.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!